136 related articles for article (PubMed ID: 11293687)
1. Prevalence of antibodies to hepatitis C virus, HIV and human T-cell leukaemia/lymphoma viruses in injecting drug users in Tayside, Scotland, 1993-7.
McIntyre PG; Hill DA; Appleyard K; Taylor A; Hutchinson S; Goldberg DJ
Epidemiol Infect; 2001 Feb; 126(1):97-101. PubMed ID: 11293687
[TBL] [Abstract][Full Text] [Related]
2. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high.
Goldberg D; Cameron S; McMenamin J
Commun Dis Public Health; 1998 Jun; 1(2):95-7. PubMed ID: 9644121
[TBL] [Abstract][Full Text] [Related]
4. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
[TBL] [Abstract][Full Text] [Related]
5. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
[TBL] [Abstract][Full Text] [Related]
6. Estimation of the number of injecting drug users attending an outreach syringe-exchange program and infection with human immunodeficiency virus (HIV) and hepatitis C virus: the AjUDE-Brasil project.
Caiaffa WT; Mingoti SA; Proietti FA; Carneiro-Proietti AB; Silva RC; Lopes AC; Doneda D
J Urban Health; 2003 Mar; 80(1):106-14. PubMed ID: 12612100
[TBL] [Abstract][Full Text] [Related]
7. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
Devi KhS; Singh NB; Singh HL; Singh YM
J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of blood-borne viruses among intravenous drug users and alcoholics in Hiroshima, Japan.
Ichimura H; Kurimura O; Tamura I; Tsukue I; Tsuchie H; Kurimura T
Int J STD AIDS; 1995; 6(6):441-3. PubMed ID: 8845404
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?
Taylor A; Goldberg D; Hutchinson S; Cameron S; Gore SM; McMenamin J; Green S; Pithie A; Fox R
J Infect; 2000 Mar; 40(2):176-83. PubMed ID: 10841096
[TBL] [Abstract][Full Text] [Related]
11. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
[TBL] [Abstract][Full Text] [Related]
12. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of HIV and HCV among injecting drug users (IDUs) in Yunnan, China].
Li D; Zheng X; Zhang G
Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):74-5. PubMed ID: 7522968
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection in Scotland: epidemiological review and public health challenges.
Hutchinson SJ; Roy KM; Wadd S; Bird SM; Taylor A; Anderson E; Shaw L; Codere G; Goldberg DJ
Scott Med J; 2006 May; 51(2):8-15. PubMed ID: 16722130
[TBL] [Abstract][Full Text] [Related]
15. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
[TBL] [Abstract][Full Text] [Related]
16. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.
Patrick DM; Tyndall MW; Cornelisse PG; Li K; Sherlock CH; Rekart ML; Strathdee SA; Currie SL; Schechter MT; O'Shaughnessy MV
CMAJ; 2001 Oct; 165(7):889-95. PubMed ID: 11599327
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection.
Hsieh MH; Tsai JJ; Hsieh MY; Huang CF; Yeh ML; Yang JF; Chang K; Lin WR; Lin CY; Chen TC; Huang JF; Dai CY; Yu ML; Chuang WL
PLoS One; 2014; 9(4):e94791. PubMed ID: 24722534
[TBL] [Abstract][Full Text] [Related]
18. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection among a cohort of Victorian injecting drug users.
Crofts N; Hopper JL; Bowden DS; Breschkin AM; Milner R; Locarnini SA
Med J Aust; 1993 Aug; 159(4):237-41. PubMed ID: 7692222
[TBL] [Abstract][Full Text] [Related]
20. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
Liu Y; Liu Y; Zou X; Chen W; Ling L
BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
